20/12/2012 - Press release
A study by the Healthcare Services Research Group at the IMIM has studied the per-patient costs associated with the pandemic influenza virus type H1N1, also called influenza A, from 2009. The study, has centred on the use of healthcare resources and sick leave due to employees’ temporary disability. This influenza affected more than 74 countries and caused some alarm due to its being declared pandemic and because several forecasts placed its financial burden at very high levels.
Més informació "Non-hospital resources, the highest health cost of influenza A"
16/02/2012 - Press release
The study proved that all of parents’ mental disorders are associated with a higher tendency of suicidal ideation among their children, but only generalised anxiety and depression are associated with the actual elaboration of suicide plans and the persistence over time of suicidal ideation, while parents’ antisocial personality and anxiety disorders are associated with children attempting suicide and its persistence over time.
23/01/2012 - Press release
Doctors and researchers of Hospital del Mar and IMIM point to an acquired mutation during treatment as the causative mechanism of therapeutic failure. This discovery leads to new perspectives to improve the efficiency of treatments, the survival of patients and to advance in customized treatments against cancer
Més informació "Identified a cause of resistance to colon cancer treatment"
25/12/2011 - Press release
For the first time, it has been discovered that neutrophils exist in the spleen without there being an infection. This important finding made by the research group on the Biology of B Cells of IMIM (Hospital del Mar Research Institute) in collaboration with researchers from Mount Sinai in New York, has also made it possible to determine that these neutrophils have an immunoregulating role.
Més informació "Discovered the existence of neutrophils in the spleen"
04/12/2011 - Press release
Nature Medicine publishes a pioneering study about a protein that regulates the expression of hundreds of genes that have a crucial role in the progression of pancreatic cancer, gliomas and possibly many other kinds of tumor. The study is directed by Pilar Navarro at the IMIM (Institut de Recerca Hospital del Mar, Barcelona) and Raúl Méndez, ICREA Research Professor at the Institute for Research in Biomedicine (IRB Barcelona).
Més informació "Discovery of a new reprogramming mechanism for tumor cells"
11/11/2011 - Press release
A study lead by a team of researchers from the Hospital del Mar and its research institute, IMIM, concludes that post-menopausal women with osteoarthritis have a 20% greater risk of experiencing bone fractures due to osteoporosis and are at greater risk of falling –nearly 30% more than post-menopausal women without osteoarthritis
26/10/2011 - Press release
New guidelines which provide an easy to use checklist for the accurate and ethical reporting of studies involving genetic or molecular risk factors for disease have been proposed by a group of international researchers among them Miquel Porta, head of the group of Clinical and molecular epidemiology of cancer at IMIM (Hospital del Mar Research Institute), and are published in this week’s PLoS Medicine
13/10/2011 - Press release
The Spanish Society of Cardiology (Sociedad Española de Cardiología or SEC) warns that the percentage of the Spanish population with a good control of cardiovascular risk factors is no higher than, at best, 65%, and at worst, 34%.
06/10/2011 - Press release
Certara , a US-based company and a leader in the provision of translational medicine services and solutions, is set to be the exclusive distributor of the software developed by Chemotargets the first spin-off of the IMIM (Instituto de Investigación Hospital del Mar, 'Hospital del Mar Research Institute') dedicated to the design of new drugs.
19/09/2011 - Press release
A team of researchers from the Hospital del Mar and IMIM, as well as from CIBER for Respiratory Diseases (CIBERES) – Carlos III Health Institute – Ministry of Science and Innovation- has lead a study proving that patients with severe COPD do not present muscular destruction until very advanced stages of the disease, especially when they still maintain a good muscle mass.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact